FindTrial
Sign In

Expression of various cancer markers in thyroid cancer

Immunohistochemical expression of CK19 and CD56 in thyroid neoplasms - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/068176
Enrollment
53
Registered
2024-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C73- Malignant neoplasm of thyroid gland

Interventions

Intervention1: BPS GMC (W): Khanpur kalan, Sonipat Intervention2: nil: nil

Sponsors

Tanu Priya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All proven cases of thyroid neoplasm

Exclusion criteria

Exclusion criteria: non neoplastic lesions of thyroid blocks could not be retrieved cases who had undergone chemotherapy and radiotherapy

Design outcomes

Primary

MeasureTime frame
CD56 and CK19Timepoint: baseline—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactTanu Priya

BPS Govt Medical College for women Khanpur Kalan Sonipat

drmonikabgathwal@gmail.com8569856332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026